Pharma packaging: Counterfeiting remains a menace
Pharma packaging firm Schott Kaisha’s Managing Director Kairus Dadachanji sees a need for the country to provide a push to the primary packaging segment as well as address the menace of counterfeiting. “The most important thing the nation needs to address is counterfeit,” he declared, pointing out how it remained an issue despite packaging being made more difficult to copy. The company is working with the office of the Drug Controller General and the Organisation of Pharmaceutical Producers of India to evolve ways and means to tackle the menace. Underscoring the need to be more strict, he favored a check by the USFDA. Primary packaging is not under the purview of FDA presently and the pharmaceutical companies did the audit, he said. Mr. Dadachanji was in Hyderabad recently for a seminar the company had organised on latest trends and developments in the pharma packaging. “The drug authorities in India and abroad explicitly require that pharmaceutical companie...